中度母体叶酸补充改善辅助生殖小鼠模型的胚胎与表观遗传不良结局
该研究在小鼠辅助生殖(ART)模型中比较对照、4倍推荐摄入量(中度)和10倍推荐摄入量(高剂量)叶酸补充对胚胎发育和表观遗传的影响,发现中度而非高剂量补充与发育迟缓胚胎比例降低相关,高剂量补充加剧ART印记基因位点的不良效应,效果存在性别差异。
要点
- 中度叶酸补充与发育迟缓胚胎比例降低相关,高剂量无此效应。
- 高剂量叶酸补充加剧ART在印记基因位点的负面效应。
- 叶酸补充纠正ART全基因组甲基化缺陷在雄性胎盘更有效,但也导致额外甲基化扰动,雄性更明显。
核心结论
- 中度而非高剂量叶酸补充与发育迟缓胚胎比例降低相关。
- 高剂量叶酸补充加剧ART在印记基因位点的负面效应。
- 叶酸补充纠正ART全基因组甲基化缺陷在雄性胎盘比雌性胎盘更有效,但也导致额外甲基化扰动,雄性更明显。
- 作者认为研究结果支持在ART期间叶酸补充剂量应适度。
研究设计与样本
- 远交系雌鼠在ART前六周至整个妊娠期分别喂食对照(啮齿类每日推荐摄入量)、中度(4倍每日推荐摄入量)或高剂量(10倍每日推荐摄入量)叶酸补充饲料。
- 小鼠ART包括超促排卵、体外受精、胚胎培养和胚胎移植。
- 收集妊娠中期胚胎和胎盘(每组n=74-99)评估发育迟缓和大体形态异常及表观遗传缺陷。
- 用亚硫酸氢盐焦磷酸测序检测配对的妊娠中期胚胎和胎盘(每组n=31-32)中四个印记基因(Snrpn、Kcnq1ot1、Peg1和H19)的甲基化。
- 用简化代表性亚硫酸氢盐测序(RRBS)检测胎盘(每性别/组6个正常胎盘)和胚胎(每组6个正常雌性胚胎;每组3个发育迟缓雌性胚胎)的全基因组DNA甲基化模式。
主要发现
- 中度而非高剂量叶酸补充与发育迟缓胚胎比例降低相关。
- 中度叶酸补充降低胚胎和胎盘组织中某些印记基因的DNA甲基化方差,高剂量补充加剧ART在印记基因位点的负面效应。
- 叶酸补充纠正雌性偏倚的异常印记基因甲基化。
- 叶酸补充纠正ART全基因组甲基化缺陷在雄性胎盘比雌性胎盘更有效,但叶酸补充也导致额外甲基化扰动,雄性更明显。
临床怎么用
- 作者认为研究结果支持在ART期间叶酸补充剂量应适度。
- 作者指出需要进行人体研究以确定ART妊娠的最佳叶酸补充水平并考虑胎儿性别。
局限性
- 尽管本研究使用的小鼠ART组合包括人类生育诊所常用技术,但可能存在物种差异。
- 需要进行人体研究以确定ART妊娠的最佳叶酸补充水平并考虑胎儿性别。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Could clinically-relevant moderate and/or high dose maternal folic acid supplementation prevent aberrant developmental and epigenetic outcomes associated with assisted reproductive technologies (ART)? SUMMARY ANSWER: Our results demonstrate dose-dependent and sex-specific effects of folic acid supplementation in ART and provide evidence that moderate dose supplements may be optimal for both sexes. WHAT IS KNOWN ALREADY: Children conceived using ART are at an increased risk for growth and genomic imprinting disorders, often associated with DNA methylation defects. Folic acid supplementation is recommended during pregnancy to prevent adverse offspring outcomes; however, the effects of folic acid supplementation in ART remain unclear. STUDY DESIGN, SIZE, DURATION: Outbred female mice were fed three folic acid-supplemented diets, control (rodent daily recommended intake or DRI; CD), moderate (4-fold DRI; 4FASD) or high (10-fold DRI; 10FASD) dose, for six weeks prior to ART and throughout gestation. Mouse ART involved a combination of superovulation, in vitro fertilisation, embryo culture and embryo transfer. PARTICIPANTS/MATERIALS, SETTING, METHODS: Midgestation embryos and placentas (n = 74-99/group) were collected; embryos were assessed for developmental delay and gross morphological abnormalities and embryos and placentas were examined for epigenetic defects. We assessed methylation at four imprinted genes (Snrpn, Kcnq1ot1, Peg1 and H19) in matched midgestation embryos and placentas (n = 31-32/group) using bisulfite pyrosequencing. In addition, we examined genome-wide DNA methylation patterns in placentas (n = 6 normal placentas per sex/group) and embryos (n = 6 normal female embryos/group; n = 3 delayed female embryos/group) using reduced representation bisulfite sequencing (RRBS). MAIN RESULTS AND THE ROLE OF CHANCE: Moderate, but not high dose supplementation, was associated with a decrease in the proportion of developmentally delayed embryos. Although moderate dose folic acid supplementation reduced DNA methylation variance at certain imprinted genes in embryonic and placental tissues, high dose supplementation exacerbated the negative effects of ART at imprinted loci. Furthermore, folic acid supplements resolved female-biased aberrant imprinted gene methylation. Supplementation was more effective at correcting ART-induced genome-wide methylation defects in male versus female placentas; however, folic acid supplementation also led to additional methylation perturbations which were more pronounced in males. LARGE-SCALE DATA: The RRBS data from this study have been submitted to the NCBI Gene Expression Omnibus under the accession number GSE123143. LIMITATIONS REASONS FOR CAUTION: Although the combination of mouse ART utilised in this study consisted of techniques commonly used in human fertility clinics, there may be species differences. Therefore, human studies, designed to determine the optimal levels of folic acid supplementation for ART pregnancies, and taking into account foetal sex, are warranted. WIDER IMPLICATIONS OF THE FINDINGS: Taken together, our findings support moderation in the dose of folic acid supplements taken during ART. STUDY FUNDING/COMPETING INTEREST(S): This work was funded by the Canadian Institutes of Health Research (FDN-148425). The authors declare no conflict of interest.
引用
- Rahimi S, Martel J, Karahan G, et al. Moderate maternal folic acid supplementation ameliorates adverse embryonic and epigenetic outcomes associated with assisted reproduction in a mouse model. Hum Reprod. 2019. PMID: 30989206. doi:10.1093/humrep/dez036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。